IFF (NYSE:IFF) today announced the extension of their three-strain Bacillus probiotic, Enviva® PRO, to pigs. By incorporating ...
Hosted on MSN23d
IFF eyeing acquisitions again as it sells off pharma unit—but no more ‘Frutaroms’“In 2025, we plan to continue to strategically reinvest in R&D, commercial, capacity, and technology as we aim to strengthen IFF and build a long-term sustainable platform that will deliver strong ...
Investors in International Flavors & Fragrances Inc. (Symbol: IFF) saw new options become available today, for the April 17th expiration. At Stock Options Channel, our YieldBoost formula has ...
IFF (IFF) “announced the extension of their three-strain Bacillus probiotic, Enviva(R) PRO, to pigs. By incorporating IFF’s probiotic into ...
In 2025, we plan to continue to strategically reinvest in R&D, commercial, capacity, and technology as we aim to strengthen IFF and build a long-term sustainable platform that will deliver strong ...
"IFF delivered a solid performance in 2024 ... and our ability to navigate challenges as we continue to create long-term value for all shareholders." Reported net sales for the full year were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback